Advanced in Microscopic Polyangiitis

Satyapal Rangaraj

Nottingham, ENG, GB 
Advanced in Microscopic Polyangiitis
Nottingham, ENG, GB 
OverviewLocationsClinical Research

Overview

Satyapal Rangaraj practices in Nottingham, United Kingdom. Rangaraj is rated as an Advanced expert by MediFind in the treatment of Microscopic Polyangiitis. Their top areas of expertise are Microscopic Polyangiitis, Granulomatosis with Polyangiitis, Systemic Lupus Erythematosus (SLE), and Psoriatic Arthritis.

Their clinical research consists of co-authoring 27 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Microscopic Polyangiitis.

Locations

Nottingham, ENG, United Kingdom
Other Locations
Great Ormond Street Hospital For Children NHS Trust, Guy's And St Thomas' NHS Foundation Trust, London, Musgrove Park Hospital, Liverpool, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Multicenter, Open-label, Efficacy, Safety, Tolerability, and Pharmacokinetic Study of Subcutaneous Ixekizumab With Adalimumab Reference Arm, in Children With Juvenile Idiopathic Arthritis Subtypes of Enthesitis-related Arthritis (Including Juvenile-Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
Multicenter, Open-label, Efficacy, Safety, Tolerability, and Pharmacokinetic Study of Subcutaneous Ixekizumab With Adalimumab Reference Arm, in Children With Juvenile Idiopathic Arthritis Subtypes of Enthesitis-related Arthritis (Including Juvenile-Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
Enrollment Status: Active_not_recruiting
Publish Date: June 05, 2025
Intervention Type: Drug
Study Drugs: Ixekizumab, Adalimumab
Study Phase: Phase 3

27 Total Publications

Validation of childhood lupus specific targets: ensuring accurate assessment of disease control in younger, lighter paediatric patients.
Validation of childhood lupus specific targets: ensuring accurate assessment of disease control in younger, lighter paediatric patients.
Journal: Rheumatology (Oxford, England)
Published: August 23, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Rangaraj's expertise for a condition
ConditionClose
      View All 11 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile